All the Mission World-Wide
All ICT Staff Worldwide
All LIMS Users
LIMS-MiMOSA Interface
GVA time
11 May 2024 (Saturday) 02:00 to
11 May 2024 (Saturday) 06:00
Manila time
11 May 2024 (Saturday) 08:00 to
11 May 2024 (Saturday) 12:00
Panama time
10 May 2024 (Friday) 19:00 to
10 May 2024 (Friday) 23:00
Dear Colleagues,
This is to advise you that there will be a production deployment of the LIMS-MIMOSA interface scheduled on 11 May 2024.
Please note that this LIMS version 2.2.3 production deployment will not have an impact on the on-going production operations as this upstream transmission service will remain inactive. Another communication will be sent once this transmission service is switched on.
The LIMS-MiMOSA interface will enable the upstream transmission of laboratory results from LIMS going to MiMOSA for selected top laboratory services.
In this initial implementation, the covered laboratory services will be as follows:
· CBC
· Hep C Test
· Chlamydia Test
· Hepatitis B PCR-Qualitative
· Cholera Screen
· HIV Test
· DNA Sample Collection
· IGRA
· eGFR
· Malaria RDT
· Gonorrhea
· Pregnancy Test
· Hba1c
· SARS-CoV-2 Antibody
· HBsAg
· SARS-CoV-2 RT-PCR
· Hemoglobin
· Serum Creatinine
· Hep B Core IgM Antibody
· Syphilis Test
· Hep B e Antigen
· Urine Dipstick 3 Param
· Hep B Surface Antibody
· Urine Microscopy
· Hep B Viral Load
The transmission of laboratory results entered in LIMS to MiMOSA will happen specifically for laboratory requests that are created in MiMOSA and has been finalized in LIMS. The full release notes can be accessed here.
There will be a downtime during the LIMS version 2.2.3 production deployment, we regret any inconvenience that may be experienced. Thank you for your understanding and cooperation.
Should you have any queries, please contact us at ICT Global User Support.
Best regards,
Global User Support